Animol is a drug discovery company that leverages the powerful combination of machine learning and DNA-encoded chemical libraries to build a proprietary pipeline of highly innovative pharmaceuticals for veterinary patients.
Employees: 1-10
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Anterra Ca... | anterracap... |
Mentions in press and media 2
| Date | Title | Description |
| 28.07.2022 | Animol Discovery, Inc. Announces Series B Financing of $34.0 million to Advance Its Pipeline of Novel Veterinary Pharmaceuticals | - |
| - | Animol Discovery | “Animol Discovery” |